BIOMAT Database Logo BIOMAT Database Logo

Remote monitoring of cardiac implantable devices during COVID-19 outbreak: "keep people safe" and "focus only on health care needs". 2021

Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Arrhythnology Department, Maria Cecilia Hospital, Cotignola, Italy.

BACKGROUND The COVID-19 pandemic has challenged the ability of health care organisations to provide adequate care. We report the experience of a national tertiary electrophysiology centre in the management of patients with cardiac implantable electronic devices (CIEDs) through the use of a fully remote follow-up model. METHODS We daily and prospectively collected remote monitoring (RM) relevant findings and following clinical actions performed from March 10th to April 3rd 2020, a period of suspension of routine ambulatory activity due to the national lockdown. RESULTS During the study period (25 days), we received 2,215 transmissions from 2,955 devices. Among them, 129 patients reported potential clinically actionable RM observations (event rate: 12.0/1000 patient-week). In 77 patients (60%), RM events triggered a clinical action, but only 5 patients needed an urgent in-hospital access (4 urgent procedures and 1 device reprogramming). CONCLUSIONS In the unprecedented COVID-19 pandemic, RM became an essential tool in healthcare delivery for CIED patients. We observed that RM was effective in "keep people safe" and "focus only on individuals with health care needs".

UI MeSH Term Description Entries
D010138 Pacemaker, Artificial A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). Cardiac Pacemaker, Artificial,Artificial Cardiac Pacemaker,Artificial Cardiac Pacemakers,Artificial Pacemaker,Artificial Pacemakers,Cardiac Pacemakers, Artificial,Pacemaker, Artificial Cardiac,Pacemakers, Artificial,Pacemakers, Artificial Cardiac
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003140 Communicable Disease Control Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man. Flatten the Curve of Epidemic,Flattening the Curve, Communicable Disease Control,Parasite Control,Control, Communicable Disease,Control, Parasite
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
D017147 Defibrillators, Implantable Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes. Cardioverter-Defibrillators, Implantable,Implantable Cardioverter Defibrillator,Implantable Cardioverter-Defibrillators,Implantable Defibrillators,Cardioverter Defibrillator, Implantable,Cardioverter Defibrillators, Implantable,Cardioverter-Defibrillator, Implantable,Defibrillator, Implantable,Defibrillator, Implantable Cardioverter,Defibrillators, Implantable Cardioverter,Implantable Cardioverter Defibrillators,Implantable Cardioverter-Defibrillator,Implantable Defibrillator
D017216 Telemedicine Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Tele-Care,Tele-ICU,Tele-Intensive Care,Tele-Referral,Telecare,Virtual Medicine,Mobile Health,Telehealth,eHealth,mHealth,Health, Mobile,Medicine, Virtual,Tele Care,Tele ICU,Tele Intensive Care,Tele Referral,Tele-Referrals

Related Publications

Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Cardiac implantable electronic devices replacements in patients followed by remote monitoring during COVID-19 lockdown.
March 2021, European heart journal. Digital health,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Boosting telemedicine through remote monitoring of cardiac electronic devices during the Italian COVID-19 outbreak.
January 2021, Cardiology journal,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
[Remote monitoring of implantable cardiac devices: health technology assessment ].
May 2015, Giornale italiano di cardiologia (2006),
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations.
March 2024, Revista espanola de cardiologia (English ed.),
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Remote Monitoring of Cardiac Implantable Electronic Devices.
July 2018, The Canadian journal of cardiology,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey.
March 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Remote monitoring for implantable cardiac electronic devices.
June 2012, Heart, lung & circulation,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic.
May 2023, Journal of cardiovascular development and disease,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Access to Care Matters: Remote Health Care Needs During COVID-19.
April 2021, Telemedicine journal and e-health : the official journal of the American Telemedicine Association,
Saverio Iacopino, and Filippo Placentino, and Jacopo Colella, and Francesca Pesce, and Antonino Pardeo, and Pasquale Filannino, and Paolo Artale, and Dalila Desiro, and Paolo Sorrenti, and Giuseppe Campagna, and Gennaro Fabiano, and Gianluca Peluso, and Daniele Giacopelli, and Andrea Petretta
Remote monitoring of cardiac implantable electronic devices (CIED).
August 2016, Trends in cardiovascular medicine,
Copied contents to your clipboard!